Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Pops Richard F
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   1,303,786    

Indirect Shares

   0      
Direct Value   $37,782,416    

Indirect Value

   $0      
Total Shares   1,303,786      
Total Value   $37,782,416      


Neurocrine Biosciences Inc $4,280,446 Alkermes Plc $27,604,395 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375 Neurocrine Biosciences Inc $4,280,446 Alkermes Plc $27,604,395 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX Director 2024-05-17 31,611 2005-11-23 0    Premium*  
            Alkermes Plc ALKS Director and CEO, Alke... 2024-02-08 1,179,675 2011-09-16 0    Premium*  
            Epizyme, Inc. EPZM Director 2013-05-30 60,000 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2019-01-25 32,500 0    Premium*  
* Premium Members only  

Records found :    259         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2020-05-14 4 AS $15.00 $1,125,233 D/D (75,000) 759,094 0 %
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2021-05-06 4 AS $21.79 $2,179,410 D/D (100,000) 792,040 0 %
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2021-05-11 4 AS $21.95 $3,313,339 D/D (150,000) 792,040 0 %
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2021-05-18 4 AS $21.90 $3,285,405 D/D (150,000) 792,040 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2022-05-09 4 AS $76.29 $1,144,463 D/D (15,000) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2023-01-03 4 AS $119.20 $1,788,045 D/D (15,000) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-02-20 4 AS $132.47 $1,987,047 D/D (15,000) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-08 4 AS $140.05 $238,078 D/D (1,700) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-11 4 AS $140.00 $14,000 D/D (100) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-13 4 AS $140.33 $3,255,621 D/D (23,200) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-05-17 4 AS $141.84 $297,860 D/D (2,100) 31,611 0 %
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2011-11-05 4 D $16.12 $10,107 D/D (627) 323,727 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-05-17 4 D $16.71 $56,630 D/D (3,389) 345,418 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-05-27 4 D $16.14 $31,973 D/D (1,981) 348,173 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-11-18 4 D $19.49 $1,015,936 D/D (52,126) 421,047 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2013-03-28 4 D $12.15 $127,198 D/D (10,469) 1,531 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-17 4 D $31.69 $121,563 D/D (3,836) 425,336 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-20 4 D $31.04 $119,038 D/D (3,835) 429,626 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-21 4 D $31.98 $122,643 D/D (3,835) 433,916 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-11-18 4 D $36.89 $2,176,547 D/D (59,001) 499,915 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2014-05-12 4 D $14.47 $148,433 D/D (10,258) 3,273 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-17 4 D $43.59 $166,993 D/D (3,831) 504,209 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-20 4 D $43.98 $168,487 D/D (3,831) 508,503 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-21 4 D $44.48 $170,403 D/D (3,831) 512,797 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-05-28 4 D $45.74 $296,578 D/D (6,484) 520,063 0 -
  259  Records found
  1   2   3   4  5   6   7   8   9   10   11      
  Page 4 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us